The store will not work correctly when cookies are disabled.
2-(6-(5-chloro-4-methylthiophen-2-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-N,N-dimethylacetamide
ID: ALA4529074
PubChem CID: 124176277
Max Phase: Preclinical
Molecular Formula: C16H16ClN3OS
Molecular Weight: 333.84
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(-c2cnc3ccn(CC(=O)N(C)C)c3c2)sc1Cl
Standard InChI: InChI=1S/C16H16ClN3OS/c1-10-6-14(22-16(10)17)11-7-13-12(18-8-11)4-5-20(13)9-15(21)19(2)3/h4-8H,9H2,1-3H3
Standard InChI Key: TXOONESNPOIHIY-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
4.6170 -22.8359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6158 -23.6555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3239 -24.0644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3221 -22.4271 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0307 -22.8323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0355 -23.6509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8155 -23.8994 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2929 -23.2343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8078 -22.5749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0725 -24.6751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8729 -24.8404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1299 -25.6161 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4161 -24.2299 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5866 -26.2265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9302 -25.7813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9078 -24.0635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1600 -23.7320 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.6128 -24.3388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0208 -25.0469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8202 -24.8775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8001 -24.2528 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.6879 -25.7932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
12 15 1 0
2 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 2 0
18 21 1 0
19 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 333.84 | Molecular Weight (Monoisotopic): 333.0703 | AlogP: 3.81 | #Rotatable Bonds: 3 |
Polar Surface Area: 38.13 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.05 | CX LogP: 3.29 | CX LogD: 3.29 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.73 | Np Likeness Score: -1.88 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |